Growing miniature tumors from a patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists.
source: Bridget Kuehn - Cornell Chronicle
Share | 
| 
| 
|
Together, we can END prostate cancer.
Donate Today